3rd Quarter - Report

TIBER CREEK GROUP for PHRMA

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

HR.1424, Paul Wellstone Mental Health and Addiction Equity Act of 2007, SEC 105: Medicaid Drug Rebates. HR. 6331, Medicare Improvements for Patients and Providers Act of 2008.

LobbyistCovered position, as disclosed
JONATHON JONES —
SHEILA MURPHY LD, Sen. Klobuchar
JEFFREY PECK —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6331 (110th), H.R. 1424 (110th)

Pharmacy PHA

HR.1424, Paul Wellstone Mental Health and Addiction Equity Act of 2007, SEC 105: Medicaid Drug Rebates. HR. 6331, Medicare Improvements for Patients and Providers Act of 2008.

LobbyistCovered position, as disclosed
JONATHON JONES —
SHEILA MURPHY LD, Sen. Klobuchar
JEFFREY PECK —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1424 (110th), H.R. 6331 (110th)

Health Issues HCR

HR.1424, Paul Wellstone Mental Health and Addiction Equity Act of 2007, SEC 105: Medicaid Drug Rebates. HR. 6331, Medicare Improvements for Patients and Providers Act of 2008.

LobbyistCovered position, as disclosed
JONATHON JONES —
SHEILA MURPHY LD, Sen. Klobuchar
JEFFREY PECK —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1424 (110th), H.R. 6331 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.